Comparative analysis of TB-Biochip, Xpert MTB/RIF, and GenoType MTBDRplus test systems for rapid determination of mutations responsible for drug resistance of M. tuberculosis complex (in sputum from patients in Moscow region)

Molecular Biology

Volumn 47, Issue 2, 2013, Pages 236-241

  Nosova, E Yu ^a   Krasnova, M A ^a   Galkina, K Yu ^a   Makarova, M V ^a   Litvinov, V I ^a   Moroz, A M ^a  

^a Moscow Scientific and Clinical Antituberculosis Center   (Russian Federation)

Author keywords

drug susceptibility testing; GenoType MTB DRplus; isoniazid; M. tuberculosis DNA; respiratory samples; rifampicin; TB Biochip; Xpert MTB RIF

Indexed keywords

MYCOBACTERIUM TUBERCULOSIS;

EID: 84876429516     PISSN: 00268933     EISSN: 16083245     Source Type: Journal    
DOI: 10.1134/S002689331301010X     Document Type: Article

References (18)

1. Centers for Disease Control and Prevention. 2009. Updated guidelines for the use of nucleic acid amplification tests in the diagnosis of tuberculosis. MMWR Morb. Mortal. Wkly. Rep. 58, 7-10.
2. O'Grady J., Maeurer M., Mwaba P., et al. 2011. New and improved diagnostics for detection of drug-resistant pulmonary tuberculosis. Curr. Opin. Pulm. Med. 17, 134-141.
3. Migliori G. 2009. Multidrug-resistant and extensively drug-resistant tuberculosis in the West Europe and United States: Epidemiology, surveillance, and control. Clin. Chest Med. 30, 637-665.
4. Nyendak M. R. 2009. New diagnostic methods for tuberculosis. Curr. Opin. Infect. Dis. 22, 174-182.
5. Boehme C. 2010. Rapid molecular detection of tuberculosis and rifampin resistance. N. Engl. J. Med. 363, 1005-1015.
6. Helb D. 2010. Rapid detection of Mycobacterium tuberculosis and rifampin resistance by use of on-demand, near-patient technology. J. Clin. Microbiol. 48, 229-237.
7. Gryadunov D. 2005. Evaluation of hybridisation on oligonucleotide microarrays for analysis of drug-resistant Mycobacterium tuberculosis. Clin. Microbiol. Infect. 11, 531-539.
8. Gryadunov D. 2011. Gel-based microarrays in clinical diagnostics in Russia. Expert. Rev. Mol. Diagn. 11, 839-853.
9. Miotto P., Piana F., Cirillo D. M, et al. 2008. Genotype MTBDRplus: A further step toward rapid identification of drug-resistant Mycobacterium tuberculosis. J. Clin. Microbiol. 46, 393-394.
10. Kent P. T., Kubica G. P. 1985. Public Health Mycobacteriology. A Guide for the Level III Laboratory. Atlanta, GA: Centers for Disease Control and Prevention.
11. The Ministry of Health of the Russian Federation, order no. 109 of March 23, 2001: On Improvement of Anti-Tuberculosis Measures in the Russian Federation, pp. 292-308.
12. Siddiqi S., Rusch-Gerdes S. 2006. MGIT Procedure Manual for Bactec MGIT 960 TB System (Also Applicable for Manual MGIT), Franklin Lakes, NJ: Beckton Dickinson. http://www. finddiagnostics. org/resource-centre/reports-brochures/071130-mgit-manual. html.
13. O'Grady J., Maeurer M., Mwaba P., et al. 2011. New and improved diagnostics for detection of drug-resistant pulmonary tuberculosis. Curr. Opin. Pulm. Med. 17, 134-141.
14. Yuan X., Zhang T., Kawakami K., et al. 2012. Molecular characterization of multidrug- and extensively drugresistant Mycobacterium tuberculosis strains in Jiangxi, China. J. Clin. Microbiol. 56, 2404-2413.
15. Poudel A., Nakajima C., Fukushima Y., et al. 2012. Molecular characterization of multidrug-resistant Mycobacterium tuberculosis isolated in Nepal. Antimicrob. Agents Chemother. 56, 2831-2836.
16. Kozhamkulov U., Akhmetova A., Rakhimova S., et al. 2011. Molecular characterization of rifampicin- and isoniazid-resistant Mycobacterium tuberculosis strains isolated in Kazakhstan. Jpn. J. Infect. Dis. 64, 253-255.
17. Armand S. 2011. Comparison of the Xpert MTB/RIF test with an IS6110-TagMan real-time PCR assay for direct detection of Mycobacterium tuberculosis in respiratory and nonrespiratory specimens. J. Clin. Microbiol. 49, 1772-1776.
18. Marlowe E. 2011. Evaluation of the Cepheid Xpert MTB/RIF assay for direct detection of Mycobacterium tuberculosis complex in respiratory specimens. J. Clin. Microbiol. 49, 1621-1623.